Back
27
25
Also listed as
PIAHY
OTC
Day Range
$1.55
$1.55
52-Week Range
$0.78
$2.45
Volume
100
50D / 200D Avg
$1.90
/
$1.62
Prev Close
$1.76
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 9.0 | 0.2 |
| P/B | 0.3 | 3.0 |
| ROE % | 5.5 | 3.6 |
| Net Margin % | 6.9 | 3.8 |
| Rev Growth 5Y % | -7.7 | 9.9 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.29
$0.26 – $0.31
|
7.20B | 1 |
| FY2026 |
$0.17
$0.16 – $0.18
|
6.16B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-24 | -$0.15 | $0.02 | +110.6% |
| 2025-08-19 | N/A | $0.01 | — |
| 2024-08-20 | N/A | $0.01 | — |
| 2024-03-19 | -$0.01 | $0.00 | +65.0% |
| 2023-12-31 | N/A | -$0.01 | — |
| 2023-08-24 | -$0.01 | -$0.01 | +20.7% |
| 2023-06-30 | N/A | -$0.03 | — |
| 2023-03-13 | -$0.02 | -$0.01 | +64.6% |
Dividend History
1 yr streakYield
0.15%
Payout Ratio
10.29%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Dec 06, 2024 | Jan 24, 2025 | $1.25 | 89.70% |
Key Takeaways
Revenue declined -7.68% annually over 5 years
Earnings grew 354.04% over the past year
Debt/Equity of 0.00 — conservative balance sheet
Generating 391.86M in free cash flow
P/E of 9.03 — trading at a low valuation
PEG of 0.46 suggests growth is underpriced
Growth
Revenue Growth (5Y)
-7.68%
Revenue (1Y)10.79%
Earnings (1Y)354.04%
FCF Growth (3Y)N/A
Quality
Return on Equity
5.47%
ROIC1.38%
Net Margin6.94%
Op. Margin3.43%
Safety
Debt / Equity
0.00
Current Ratio2.70
Interest Coverage70.05
Valuation
P/E Ratio
9.03
Forward P/E8.91
P/B Ratio0.34
EV/EBITDA5.37
Dividend Yield0.15%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10.79% | Revenue Growth (3Y) | 6.76% |
| Earnings Growth (1Y) | 354.04% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -7.68% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 5.33B | Net Income (TTM) | 369.72M |
| ROE | 5.47% | ROA | 2.79% |
| Gross Margin | 32.41% | Operating Margin | 3.43% |
| Net Margin | 6.94% | Free Cash Flow (TTM) | 391.86M |
| ROIC | 1.38% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 2.70 |
| Interest Coverage | 70.05 | ||
| Dividends | |||
| Dividend Yield | 0.15% | Payout Ratio | 10.29% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 1 yrs | ||
| Valuation | |||
| P/E Ratio | 9.03 | Forward P/E | 8.91 |
| P/B Ratio | 0.34 | P/S Ratio | 0.63 |
| PEG Ratio | 0.46 | Forward PEG | N/A |
| EV/EBITDA | 5.37 | Fwd EV/EBITDA | N/A |
| Forward P/S | 0.54 | Fwd Earnings Yield | 11.22% |
| FCF Yield | 11.73% | ||
| Market Cap | 3.34B | Enterprise Value | 981.95M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.33B | 4.81B | 4.67B | 6.21B | 7.33B |
| Net Income | 369.72M | 81.43M | -322.59M | -636.06M | -1.54B |
| EPS (Diluted) | 0.18 | 0.08 | -0.30 | -0.59 | -1.39 |
| Gross Profit | 1.73B | 1.52B | 1.51B | 1.67B | 1.71B |
| Operating Income | 182.76M | -89.06M | -575.26M | -726.34M | -1.64B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 13.24B | 16.78B | 16.52B | 17.14B | 17.88B |
| Total Liabilities | 3.33B | 13.20B | 3.25B | 3.68B | 3.79B |
| Shareholders' Equity | 9.92B | 3.59B | 13.28B | 13.46B | 14.08B |
| Total Debt | 39.81M | 45.00M | 93.61M | 176.49M | 201.30M |
| Cash & Equivalents | 2.40B | 2.04B | 1.87B | 3.70B | 3.06B |
| Current Assets | 8.69B | 13.40B | 13.33B | 12.46B | 12.76B |
| Current Liabilities | 3.22B | 13.08B | 3.10B | 3.45B | 3.67B |
Strategy Scores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#894 of 1049
#684 of 826
Recent Activity
Entered
Cash Flow Compounder
Mar 26, 2026
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026
